| Stage | WOR | % of rev | FRD | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $344M | 100.00% | $240M | 100.00% | WOR ×1.43 |
| Gross profit | $91M | 26.43% | $42M | 17.64% | WOR +8.8pp |
| Operating income | $13M | 3.79% | $21M | 8.77% | FRD +5.0pp |
| Pre-tax income | $56M | 16.17% | $17M | 7.07% | WOR +9.1pp |
| Net income | $43M | 12.38% | $13M | 5.33% | WOR +7.1pp |
| Stage | WOR | FRD | Gap · A − B |
|---|---|---|---|
| Revenue | $344M100.00% | $240M100.00% | WOR ×1.43 |
| Gross profit | 26.43%$91M | 17.64%$42M | WOR +8.8pp |
| Operating income | 3.79%$13M | 8.77%$21M | FRD +5.0pp |
| Pre-tax income | 16.17%$56M | 7.07%$17M | WOR +9.1pp |
| Net income |
| 12.38%$43M |
| 5.33%$13M |
| WOR +7.1pp |
None
No disclosed counterparties: WOR.